A Clinic-Based Telehealth Program to Deliver Preventive Cardiology Care (CardioClick): Observational Study
ABSTRACT
Background:
Telehealth use has increased in specialty clinics, but there is limited evidence on outcomes of telehealth in primary cardiovascular disease (CVD) prevention.
Objective:
The objective of our study was to evaluate the initial outcomes of CardioClick, a telehealth primary CVD prevention program.
Methods:
In 2017, the Stanford South Asian Translational Heart Initiative, a preventive cardiology clinic focused on high-risk South Asian patients, introduced CardioClick, a program replacing in-person follow-up visits with video visits. We assessed patient engagement and changes in CVD risk factors for CardioClick patients and a historical cohort from the same clinic.
Results:
A total of 118 CardioClick patients and 441 patients who received in-person care were included. CardioClick patients were more likely to complete the CVD prevention program (64% vs 39%, P<.001) and did so in less time (mean 250 vs 307 days, P<.001). Patients completing CardioClick achieved reductions in risk factors, including blood pressure, lipids, and BMI, which were comparable to those observed in the historical in-person cohort.
Conclusions:
Telehealth can be used effectively to deliver care in a preventive cardiology clinic setting and may result in increased patient engagement. Further study of telehealth outcomes is needed to determine the optimal role for virtual care models across diverse preventive medicine clinics.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.